Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by G1945Von Dec 21, 2022 8:42am
141 Views
Post# 35184154

RE:RE:1.2 billion fully diluted shares but $50 billion...

RE:RE:1.2 billion fully diluted shares but $50 billion...",,,,we on this end have discussed this deal again siince the webinar and we are still siding as a no vote!"

narmac, I believe there needs to be a 65% yes vote for the deal to pass. 

Don't know what to make of it that only 2 Million + shares have been traded since trading resumed on Dec 13, 2022, out of the 77 Million + shares held by the general public for BTI. This means that the vote can go in either direction. Up or down! 

MTP is largely held by institutional investors. A good chance the MTP vote will pass.

jmo
G1945V

<< Previous
Bullboard Posts
Next >>